Skip to main content

Day: July 15, 2020

Orchid Island Capital Announces Estimated Second Quarter 2020 Results, July 2020 Monthly Dividend and June 30, 2020 RMBS Portfolio Characteristics

July 2020 Monthly Dividend of $0.06 Per ShareEstimated Book Value Per Share as of June 30, 2020 of $5.22Estimated GAAP net income of $0.74 per share for the quarter ended June 30, 2020, including an estimated $0.43 per share of net realized and unrealized gains on RMBS and derivative instrumentsEstimated 15.8% total return on equity for the quarterEstimated book value, net income and total return on equity amounts are preliminary, subject to change, and subject to review by the Company’s independent registered public accounting firmRMBS Portfolio Characteristics as of June 30, 2020Next Dividend Announcement Expected August 19, 2020VERO BEACH, Fla., July 15, 2020 (GLOBE NEWSWIRE) — Orchid Island Capital, Inc. (the “Company”) (NYSE:ORC) announced today that the Board of Directors (the “Board”) declared a monthly cash dividend for...

Continue reading

Bank OZK Announces Sale of its South Carolina Branches

LITTLE ROCK, Ark., July 15, 2020 (GLOBE NEWSWIRE) — Bank OZK (the “Bank”) (Nasdaq: OZK) today announced that it has entered into a Purchase and Assumption Agreement to sell its only two South Carolina branches.  The Bank has agreed to sell its Hilton Head Island and Bluffton, South Carolina branches (the “Branches”) to Sharonview Federal Credit Union (“Sharonview”) headquartered in Indian Land, South Carolina.Pursuant to the terms of the Purchase and Assumption Agreement, Sharonview has agreed to assume certain deposit liabilities and to acquire certain loans, as well as cash, real property, personal property and other fixed assets associated with the Branches.  Subject to obtaining the necessary regulatory approvals, the pending sale is expected to close in the fourth quarter of 2020 and should result in a small gain on sale. ...

Continue reading

Nevada Copper Provides Update on Public Offering and Announces Filing of Preliminary Prospectus

All dollar amounts are presented in Canadian dollars unless otherwise noted.YERINGTON, Nev., July 15, 2020 (GLOBE NEWSWIRE) — Nevada Copper Corp. (TSX: NCU) (“Nevada Copper” or the “Company’’) is pleased to announce that it has filed and obtained a receipt for a short form preliminary prospectus with the securities regulatory authorities in each of the provinces of Canada, except Quebec, in connection with its previously announced offering whereby a syndicate of underwriters comprised of Scotiabank, RBC Capital Markets and National Bank Financial Inc., acting together as joint bookrunners, and Haywood Securities Inc. (collectively, the “Underwriters”), agreed to buy on a bought deal basis 643,713,553 units of the Company (the “Units”) at a price of $0.15 per Unit (the “Offering Price”) for aggregate gross proceeds of approximately...

Continue reading

CytoDyn Files Application with Nasdaq for Uplist

VANCOUVER, Washington, July 15, 2020 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today it recently filed a comprehensive listing application package with The Nasdaq Stock Market to request an uplisting of the Company’s common stock.  The Company believes it satisfies the initial listing requirements for The Nasdaq Capital Market®.Nader Pourhassan, Ph.D., President and Chief Executive Officer of CytoDyn, commented: “While we realize the regulatory review of our application to uplist to Nasdaq will take several weeks, we believe the Company is well positioned for success.  As we advance the evaluation of our drug, leronlimab, including the upcoming...

Continue reading

New Millennium Iron Corp. Receives Notice of Delisting Review by TSX

CALGARY, Alberta, July 15, 2020 (GLOBE NEWSWIRE) — New Millennium Iron Corp. (the “Company” or “NML”) announces that it has received notice from the Toronto Stock Exchange (the “TSX”) that the TSX is reviewing the eligibility of the Company’s securities for continued listing on the TSX pursuant to Part VII of the TSX Company Manual (the “Manual”).NML is being reviewed under the TSX’s remedial review process and has been granted 120 days to comply with all requirements for continued listing. If NML cannot demonstrate that it meets all TSX requirements set out in Part VII of the Manual on or before November 12, 2020, the Company’s securities will be delisted 30 days from such date. The Company’s listed shares (TSX: NML) will continue to trade on the TSX during the remedial review process. There can be no assurance that the Company...

Continue reading

IntelGenx Reports Amendment of Stock Option Plan

SAINT LAURENT, Quebec, July 15, 2020 (GLOBE NEWSWIRE) — IntelGenx Technologies Corp. (TSX-V: IGX) (OTCQB: IGXT) (the “Company” or “IntelGenx”) reported today, that the Company’s Board of Directors approved an amendment to the Amended 2016 Stock Option Plan (the “Plan”) to increase the number of shares available for issuances under the Plan by 1,678,218 from 9,347,747 to 11,025,965, or 10% of the Company’s currently issued and outstanding shares.Furthermore, the Board approved an amendment to the provision concerning the automatic extension of the expiry time of stock options during blackout periods as per the TSX-V Exchange Policy. The Board resolved to remove the condition that the automatic extension during blackout periods needs to be reflected in individual stock option agreements. The amendments are subject to TSX-Venture...

Continue reading

Stewart & Stevenson’s Apollo ABVM Receives Emergency Use Authorization from U.S. Food and Drug Administration

HOUSTON, July 15, 2020 (GLOBE NEWSWIRE) — Stewart & Stevenson  Healthcare Technologies, LLC (“S&S”), a subsidiary of Kirby Corporation (“Kirby”) (NYSE: KEX), has received emergency use authorization  for the Apollo ABVM from the U.S. Food and Drug Administration (“FDA”) for the duration of emergency circumstances caused by the COVID-19 pandemic1. With this authorization, the Apollo ABVM can now be used by patients during the COVID-19 pandemic for continuous or intermittent mechanical ventilation under the emergency use authorization guidelines.The Apollo ABVM, which is based on a design created in Rice University’s Osman Engineering Design Kitchen, was refined by S&S to meet the standard for FDA emergency use authorization and make it ready for high volume production. It is an emergency device intended for healthcare...

Continue reading

Greenfields Petroleum Corporation Reports 2019 Year End Reserves and Announces Update on the Filing of 2019 Year-End and 2020 First Quarter Results and Extension of Debt Payment

HOUSTON, July 15, 2020 (GLOBE NEWSWIRE) — Greenfields Petroleum Corporation (“Greenfields” or the “Company”; TSX-VENTURE: GNF) is pleased to announce the Company’s oil, natural gas and natural gas liquids (“NGL”) reserves as at December 31, 2019, as evaluated by an independent qualified reserves evaluator, Wisholm Geosciences Inc. (“WGI”), in an independent report (the “WGI Report”) as well as a progress update on the extension of its senior debt payment. In addition to the summary information disclosed in this announcement, more detailed information is included in Greenfields’ statement of reserves data as at December 31, 2019 which has been filed on the Company’s SEDAR profile at www.sedar.com. All amounts herein are in United States dollars.WGI REPORTAs at December 31, 2019, the proved reserves net to the Company through its interest...

Continue reading

ERES REIT Declares July 2020 Monthly Distribution

TORONTO, July 15, 2020 (GLOBE NEWSWIRE) — European Residential Real Estate Investment Trust (TSX: ERE.UN, “ERES”) is pleased to announce that the trustees of ERES have declared the July 2020 monthly cash distribution of €0.00875 per Unit and Class B LP Unit (the “July Distribution”), being equivalent to €0.105 per Unit annualized. The distribution will be payable to holders of the Units and Class B LP Units (the “Unitholders”) of record on July 31, 2020, with payment on August 17, 2020.

Continue reading

CAPREIT Announces July 2020 Distribution

TORONTO, July 15, 2020 (GLOBE NEWSWIRE) — Canadian Apartment Properties Real Estate Investment Trust (“CAPREIT”) (TSX – CAR.UN) announced today its July 2020 monthly distribution in the amount of $0.11500 per Unit (or $1.38 on an annualized basis). The July distribution will be payable on August 17, 2020 to Unitholders of record on July 31, 2020.To encourage participation and reward our loyal Unitholders, investors registered in our Distribution Reinvestment Plan will continue to receive an additional amount equal to 5% of their distributions paid in the form of additional Units.CAPREIT is one of Canada’s largest real estate investment trusts. CAPREIT owns approximately 56,600 suites, including townhomes and manufactured housing sites, in Canada and, indirectly through its investment in ERES, approximately 5,600 suites in the Netherlands....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.